![]() |
市場調查報告書
商品編碼
2160805
2034年新型蛋白質來源市場預測-按蛋白質來源、產品、功能特性、應用、最終用戶和地區分類的全球分析Novel Protein Ingredients Market Forecasts to 2034 - Global Analysis By Protein Source, Product, Functional Property, Application, End User, and Geography |
||||||
據 Stratistics MRC 稱,到 2026 年,全球新型蛋白質原料市場規模將達到 82 億美元,預計在預測期內將以 14.6% 的複合年成長率成長,到 2034 年將達到 245 億美元。
新型蛋白質來源是指利用替代生物、微生物、植物來源或發酵系統開發的新興蛋白質來源,旨在提供傳統動物和植物蛋白質以外的全新營養和功能選擇。這些來源包括微生物蛋白、藻類蛋白、昆蟲蛋白、發酵衍生蛋白、培養蛋白以及源自非常規作物和製作流程的蛋白。它們被添加到肉類替代品、乳製品替代品、營養產品、零食、飲料、烘焙產品和機能性食品中。其關鍵特性包括蛋白質品質、消化率、胺基酸組成、口感、質地、溶解性和加工性能。由於人口成長、永續性、蛋白質多樣化以及消費者對新型食品技術的興趣日益濃厚,市場對新型蛋白質來源的需求不斷成長。生產商正致力於改進萃取、發酵、細胞培養和配方技術,以提高產品性能並降低生產成本。創新目標日益追求中性風味、更高蛋白質濃度、更強的功能性以及與主流食品應用的融合。
市場動態
對永續蛋白質來源的需求日益成長
受人口成長和開發中國家肉類消費量增加的推動,全球蛋白質需求不斷上升,對傳統蛋白質供應造成壓力,並促使人們對新型蛋白質來源產生濃厚興趣。人們對畜牧業環境影響的認知不斷提高,也推動了替代蛋白質的普及。對新型蛋白質研發投入的增加,加速了其商業化進程。消費者對新穎和非常規蛋白質來源日益成長的興趣,也促進了市場擴張。對糧食安全的擔憂以及為提高供應鏈韌性所做的努力,也促使人們對多樣化蛋白質來源的需求不斷成長。
與監管和消費者接受度相關的挑戰
不同地區對新型蛋白質來源的法規核准要求各不相同,核准過程可能耗時耗力。消費者對包括昆蟲蛋白質和細胞培養蛋白在內的新型蛋白質來源的接受度可能受到文化和心理因素的限制。產能不足限制了新型蛋白質來源的供應。高昂的生產成本影響了其與傳統蛋白質的價格競爭力。缺乏成熟的供應鏈和應用知識限制了市場發展。
技術進步和成本降低
生產技術的進步,包括發酵和細胞培養,正在降低成本並提高新型蛋白質原料的規模化生產能力。加工方法的改進增強了其功能性並拓展了潛在應用。對新型蛋白質生產能力的投資增加正在推動市場擴張。新型蛋白質新應用的開發正在創造新的市場機會。新興市場為新型蛋白質原料蘊藏著巨大的成長潛力。
與現有蛋白質來源的競爭
來自傳統蛋白質和植物來源蛋白的競爭可能會限制新型蛋白質來源在某些應用領域的推廣。經濟壓力可能會影響對新型蛋白質生產能力的投資。影響新食品核准的監管變化可能會影響市場發展。消費者對新型蛋白質的懷疑態度可能會影響其普及化。新型蛋白質的快速成長正在吸引新的參與者,並加劇競爭。
新冠感染疾病凸顯了傳統蛋白質供應鏈的脆弱性,並加速了人們對替代蛋白質來源的興趣。消費者對健康和永續性的日益關注正在推動市場擴張。疫情後時期,對新型蛋白質研發的投資增加。食品體系的轉型持續推動創新。消費者對替代蛋白質的認知度也不斷提高。
在預測期內,發酵衍生蛋白質細分市場預計將佔據最大的市場佔有率。
預計在預測期內,發酵衍生蛋白將佔據最大的市場佔有率。這是因為發酵衍生蛋白是商業性程度最高、規模化潛力最大的新蛋白質類別。市場對真菌蛋白、酵母蛋白和其他發酵衍生蛋白的需求不斷成長,推動了市場擴張。發酵技術的進步提高了生產效率並降低了成本。完善的生產基礎設施和應用知識鞏固了該領域的領先地位。發酵衍生蛋白在永續性和營養價值方面具有卓越的特性。
預計在預測期內,真菌蛋白細分市場將呈現最高的複合年成長率。
在預測期內,受肉類替代品和其他食品應用中真菌蛋白日益廣泛的應用所推動,真菌蛋白細分市場預計將呈現最高的成長率。真菌蛋白的特點是營養價值高、功能性好且生產過程永續。對真菌蛋白生產能力的投資增加正在推動市場擴張。真菌發酵技術的進步正在提高生產效率和產品品質。真菌蛋白在潔淨標示和永續食品中越來越受歡迎。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於該地區眾多新興蛋白質公司的強大實力、先進的生物技術基礎設施以及對替代蛋白質的早期應用。美國擁有多家大型新興蛋白質公司,並具備成熟的生產能力。消費者對永續性意識的不斷增強也推動了市場擴張。食品技術投資的持續成長進一步鞏固了該地區的市場領導地位。大型食品製造商正與新興蛋白質公司合作,將創新成分商業化。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於蛋白質需求的成長、對替代蛋白投資的增加以及永續性的提高。中國、印度和東南亞國家正在推動新增蛋白質產能的擴張。日益成長的糧食安全擔憂和不斷增強的環保意識也在加速市場成長。政府對替代蛋白發展的支持創造了良好的投資環境。區域食品企業正擴大採用新的蛋白質來源。
According to Stratistics MRC, the Global Novel Protein Ingredients Market is accounted for $8.2 billion in 2026 and is expected to reach $24.5 billion by 2034 growing at a CAGR of 14.6% during the forecast period. Novel Protein Ingredients are emerging protein sources developed from alternative biological, microbial, plant, or fermentation-based systems to provide new nutritional and functional options beyond conventional animal and plant proteins. These ingredients include microbial proteins, algae proteins, insect proteins, fermentation-derived proteins, cultivated proteins, and proteins from unconventional crops or processing streams. They are incorporated into meat alternatives, dairy alternatives, nutrition products, snacks, beverages, bakery products, and functional foods. Important characteristics include protein quality, digestibility, amino acid composition, taste, texture, solubility, and processing performance. Demand is increasing because of population growth, sustainability concerns, protein diversification, and consumer interest in new food technologies. Producers are investing in improved extraction, fermentation, cell cultivation, and formulation technologies to enhance performance and reduce production costs. Innovation increasingly targets neutral flavor, higher protein concentration, improved functionality, and integration into mainstream food applications.
Market Dynamics
Growing demand for sustainable protein sources
Increasing global demand for protein, driven by population growth and rising meat consumption in developing countries, is creating pressure on conventional protein supply and driving interest in novel protein sources. Growing awareness of the environmental impact of animal agriculture supports adoption of alternative proteins. Rising investment in novel protein research and development accelerates commercialization. Growing consumer interest in novel and exotic protein sources supports market expansion. Food security concerns and supply chain resilience initiatives drive interest in diversified protein sources.
Regulatory and consumer acceptance challenges
Regulatory approval requirements for novel protein ingredients vary across regions and can be lengthy and costly. Consumer acceptance of novel protein sources including insects and cell-cultured proteins may be limited by cultural and psychological factors. Limited availability of production capacity constrains supply for novel protein ingredients. High production costs affect price competitiveness with conventional proteins. Lack of established supply chains and application knowledge limits market development.
Technological advancements and cost reduction
Advances in production technologies including fermentation and cell culture are reducing costs and improving scalability of novel protein ingredients. Development of improved processing methods enhances functionality and expands application possibilities. Growing investment in novel protein production capacity supports market expansion. Expansion of novel proteins into new applications creates market opportunities. Emerging markets offer significant growth potential for novel protein ingredients.
Competition from established protein sources
Competition from conventional proteins and plant-based proteins may limit adoption of novel protein ingredients in certain applications. Economic pressures may affect investment in novel protein production capacity. Regulatory changes affecting novel food approval may impact market development. Consumer skepticism regarding novel proteins may affect adoption. Rapid growth of novel proteins attracts new entrants and intensifies competition.
The COVID-19 pandemic highlighted vulnerabilities in conventional protein supply chains and accelerated interest in alternative protein sources. Growing consumer focus on health and sustainability supports market expansion. The post-pandemic period has witnessed increased investment in novel protein research and development. Food system transformation continues driving innovation. Consumer awareness of alternative proteins continues growing.
The fermentation-derived proteins segment is expected to be the largest during the forecast period
The fermentation-derived proteins segment is expected to account for the largest market share during the forecast period as fermentation-derived proteins represent the most commercially advanced and scalable novel protein category. Growing demand for mycoprotein, yeast protein, and other fermentation-derived proteins drives market expansion. Advances in fermentation technology improve production efficiency and reduce costs. Established production infrastructure and application knowledge support segment leadership. Fermentation-derived proteins offer favorable sustainability and nutritional profiles.
The fungal proteins segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the fungal proteins segment is predicted to witness the highest growth rate driven by increasing adoption of fungal proteins in meat alternatives and other food applications. Fungal proteins offer favorable nutritional profiles, good functionality, and sustainable production. Growing investment in fungal protein production capacity supports market expansion. Advances in fungal fermentation improve production efficiency and product quality. Fungal proteins are increasingly preferred for clean-label and sustainable food products.
During the forecast period, the North America region is expected to hold the largest market share owing to strong presence of novel protein companies, advanced biotechnology infrastructure, and early adoption of alternative proteins. The United States hosts major novel protein companies with established production capabilities. High consumer awareness of sustainability supports market expansion. Growing investment in food technology reinforces regional market leadership. Major food manufacturers are partnering with novel protein companies to commercialize innovative ingredients.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by growing protein demand, increasing investment in alternative proteins, and rising awareness of sustainability. China, India, and Southeast Asian countries are expanding novel protein production capabilities. Growing food security concerns and environmental awareness accelerate market growth. Government support for alternative protein development creates favorable investment environment. Regional food companies are increasingly adopting novel protein ingredients.
Key players in the market
Some of the key players in the Novel Protein Ingredients Market include ADM, Roquette Freres, Corbion N.V., Quorn Foods, Entomo Farms, Ynsect, Aqua Cultured Foods, Nature's Fynd, BioTech Foods, MycoTechnology, Inc., Ginkgo Bioworks Holdings, Inc., Perfect Day, Inc., Enough Ltd., Algenuity, and Calysta, Inc.
In June 2026, Nature's Fynd announced the commercial launch of its fungal protein ingredient for meat alternative applications following successful regulatory approval in the United States. This launch represents a significant milestone in commercializing novel protein ingredients derived from fungal fermentation.
In February 2026, Enough Ltd. announced the expansion of its mycoprotein production capacity in Europe to meet growing demand from food manufacturers. The expansion includes new fermentation and downstream processing facilities designed to increase production capacity by 50%.
In October 2025, MycoTechnology, Inc. launched a new range of fungal protein ingredients for dairy alternative applications. The products offer improved taste and texture compared to earlier generations of plant-based proteins.
In June 2025, Ynsect announced the development of a new insect protein ingredient with enhanced functional properties for food applications. This development addresses key technical challenges limiting adoption of insect proteins in food products.
In February 2025, ADM expanded its novel protein ingredient portfolio with new fermentation-derived proteins for sports nutrition applications. This expansion addresses growing demand for sustainable protein ingredients in sports nutrition products.
In October 2024, Roquette Freres announced a significant investment in novel protein production capacity in Europe. The investment includes new fermentation and processing facilities for producing fungal and fermentation-derived proteins.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.